Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Closed 07-29 16:00:00 EDT

988.88

-4.10

-0.41%

High998.51	Low985.95	Vol368.62M
Open992.98	D1 Closing992.98	Amplitude1.27%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O12.57B	T/O Rate--	Tradable Shares0.00
P/B5.741749	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":988.8836,"timestamp":1785355199999,"preClose":992.98346,"halted":0,"volume":368622203,"delay":0,"changeRate":-0.004129,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-4.099854,"latestTime":"07-29 16:00:00 EDT","open":992.9836,"high":998.5079,"low":985.9451,"amount":12572622632.3789,"amplitude":0.012652,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1785369600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.741749,"peRate":30.072048,"turnoverRate":0.008301,"increases":59,"decrements":120,"flats":10,"marketCap":3838361411817.8125,"floatMarketCap":3676620293405.4688},"requestUrl":"/m/hq/s/BK4007/wiki","defaultTab":"wiki","newsList":[{"id":"2655811152","title":"SenesTech Schedules Q2 2026 Earnings Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655811152","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655811152?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:41","pubTimestamp":1785357670,"startTime":"0","endTime":"0","summary":"SenesTech schedules Q2 2026 earnings release and conference callSenesTech schedules Q2 2026 results release for Aug. 5, 2026, timed for market close.Earnings conference call set for Aug. 5, 2026 at 5:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL8bmxvG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNES","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655811610","title":"EU Authorizes Pfizer-BioNTech XFG-adapted COVID Vaccine for Ages 6 Months and Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2655811610","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655811610?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:39","pubTimestamp":1785357578,"startTime":"0","endTime":"0","summary":"EU authorizes Pfizer-BioNTech XFG-adapted COVID vaccine for ages 6 months and upEuropean Commission granted marketing authorization for Pfizer-BioNTech’s 2026-2027 monovalent COVID-19 vaccine targetin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDLb2qxnl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4548","BK4581","IE00BBT3K403.USD","BK4599","OZEM","LU0456855351.SGD","BK4592","LU0170899867.USD","BK4551","LU1057294990.SGD","LU0306807586.USD","BK4533","BNTX","LU2596442595.SGD","SG9999003800.SGD","LU0058720904.USD","BK4588","LU1066051498.USD","PFE","BK4534","BK4550","LU0306806265.USD","SG9999001176.SGD","IE00B19Z3581.USD","IE00BLSP4452.SGD","BK4139","IE0002270589.USD","LU1894683348.USD","SG9999002224.SGD","LU0225284248.USD","BK4007","LU0225771236.USD","LU0289739699.SGD","BK4585","LU0321505439.SGD","LU0321505868.SGD","LU0122379950.USD","IE00B3T34201.USD","SG9999011175.SGD","SG9999013999.USD","LU1023059063.AUD","SG9999002232.USD","SG9999001176.USD","LU1894683264.USD","IE000M9KFDE8.USD","LU0234572021.USD","LU0868494617.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU0985481810.HKD","LU1066053197.SGD","LU1883839398.USD","SGXZ57979304.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655819075","title":"Merck & Co. Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2655819075","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655819075?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:33","pubTimestamp":1785357180,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  shed 1.11% to $130.36 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.52% to 7,316.15 and Dow Jones Industrial Average  falling 2.19% to 51,594.14.Merck & Co. Inc. closed 3.47% short of its 52-week high of $135.05, which the company achieved on July 28th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.45% to $265.53, Pfizer Inc.  fell 0.40% to $25.15, and Eli Lilly & Co.  fell 0.87% to $1,210.02.Trading volume  remained 4.1 million below its 50-day average volume of 10.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 29, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965508806.USD","LU1430594728.SGD","SG9999002232.USD","LU0942090050.USD","SG9999014575.USD","SG9999014567.USD","SG9999014542.SGD","LU0320765646.SGD","LU2361045086.USD","LU0868494708.USD","SG9999002224.SGD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1974910355.USD","BK4585","IE00BFTCPJ56.SGD","LU1989771016.USD","LU0965509010.AUD","LU1037948897.HKD","LU0265550946.USD","LU0122379950.USD","IE000M9KFDE8.USD","LU1066051498.USD","BMED","RXL","SGXZ57979304.SGD","SG9999001176.USD","SG9999015358.SGD","GDOC","SG9999015341.SGD","IYH","SG9999001176.SGD","BK4550","BK4007","LU1116320737.USD","LU1585245621.USD","BK4516","LU2491050154.USD","LU2324357040.USD","LU1291159041.SGD","BK4588","PAWZ","SG9999014559.SGD","LU0289739699.SGD","LU2360032135.SGD","IE0002141913.USD","LU0689626769.HKD","LU1061106388.HKD","LU1917777945.USD","IE00B4R5TH58.HKD","LU2125909247.SGD","LU2125154935.USD","FTXH","LU0985320562.USD","LU1929549753.HKD","LU0130517989.USD","LU1066053197.SGD","IE00BSNM7G36.USD","LU1934455194.USD","LU2023250843.SGD","LU2023250504.SGD","LU2361044949.HKD","BK4533","LU0058720904.USD","LU0868494617.USD","LU2089984988.USD","LU0965509283.SGD","IXJ","LU0124676726.USD","TRUH","LU2433249047.HKD","LU1923622614.USD","IE00BN8TJ469.HKD","LU0130102774.USD","LU2112291526.USD","LU0266013472.USD","IE00B2B36J28.USD","LU1162221912.USD","LU2468319806.SGD","LU0106261372.USD","LU1989772923.USD","LU1066051225.USD","LU0234572021.USD","LU1941712348.USD","LU2125909593.SGD","LU2491050071.SGD","LU2106854487.HKD","VHT","LU0006306889.USD","LU0477156953.USD","LU1699723380.USD","LU2361044865.SGD","LU1093756168.USD","MRK","IE00BLSP4239.USD","JDOC","LU0648001328.SGD","LU1983299246.USD","SG9999001440.SGD","LU1116320901.HKD","LU1571399168.USD","LU1035773651.USD","LU1057294990.SGD","LU2125154778.USD","XLV","LU0203345920.USD","LU2461242641.AUD","LU0859254822.USD","LU1066051811.HKD","LU1934455863.HKD","LU1069347547.HKD","IE00BBT3K403.USD","LU0980610538.SGD","LU2357627491.SGD","SG9999013999.USD","LU1023059063.AUD","LU0320765489.SGD","BK4534","LU0861579265.USD","LU1037948541.HKD","LU1941712264.USD","LU2491049909.HKD","FHLC","LU0432979614.USD","IE00BJT1NW94.SGD","LU0211331839.USD","IHE","IE00B1BXHZ80.USD","LU0965509101.SGD","HRTS","LU0208291251.USD","LU1201861249.SGD","LU0098860793.USD","LU0070302665.USD","BK4559","LU0238689110.USD","LU1934455277.USD","LU0203347892.USD","IE0009355771.USD","IE00BLSP4452.SGD","LU0265550359.USD","LU1989772840.SGD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655819873","title":"60 Degrees Pharma Hits Minimum Enrollment Trigger for Interim Readout in Severe Babesiosis Tafenoquine Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2655819873","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655819873?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:16","pubTimestamp":1785356217,"startTime":"0","endTime":"0","summary":"60 Degrees Pharma hits minimum enrollment trigger for interim readout in severe babesiosis tafenoquine trial60 Degrees Pharmaceuticals reached the minimum 24-patient enrollment for an interim analysis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4jkZ8n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816067","title":"Corcept Therapeutics Q2 EPS USD 0.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816067","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816067?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:16","pubTimestamp":1785356177,"startTime":"0","endTime":"0","summary":"Jul 29 (Reuters) - Corcept Therapeutics Q2 revenue USD 256.147 million.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 29-JUL-202615:42:50 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nRSD73tzLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","PSCH","FBT","CORT","LU1559883803.SGD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655581677","title":"Corcept Q2 FY26 Net Income Rises to $43 Million; Revenue Climbs 32% to $256.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655581677","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655581677?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:15","pubTimestamp":1785356143,"startTime":"0","endTime":"0","summary":"Corcept Q2 FY26 net income rises to $43 million; revenue climbs 32% to $256.1 millionCorcept Q2 revenue rose 32% to USD 256.1 million, with Korlym and authorized generic at USD 208.6 million and Lifyo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL3dG2zq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","LU0566484027.USD","BK4532","BK4007","LU1559883803.SGD","FBT","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655162788","title":"Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2655162788","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655162788?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:13","pubTimestamp":1785355980,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics Q2 revenue estimates, raises 2026 outlookOverviewU.S. biopharma firm's Q2 revenue rose 32% yr/yr, beating analyst expectationsNet income for Q2 increased to $43.0 mln from $35.1 m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL1N43V1C6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","FBT","IE00B19Z9Z06.USD","LU0566484027.USD","CORT","BK4585","BIIB","IE00B19Z9P08.USD","BK4550","PSCH","LU0109394709.USD","BK4007","LU1559883803.SGD","BK4532","IE00B894F039.SGD","LU0889565916.HKD","LU0320765992.SGD","IDNA","BMED","PBE","BK4533","BK4139","BK4588","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816904","title":"Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816904","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816904?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:09","pubTimestamp":1785355793,"startTime":"0","endTime":"0","summary":"Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/BHC","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816359","title":"60 Degrees Pharmaceuticals Files Form 3 Showing Knight Therapeutics Stake of 658,629 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816359","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816359?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:07","pubTimestamp":1785355636,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals files Form 3 showing Knight Therapeutics stake of 658,629 sharesKnight Therapeutics filed a Form 3 showing it holds 658,629 shares of 60 Degrees Pharmaceuticals common stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL7g1TRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816388","title":"Rapport Therapeutics CEO Abraham Ceesay Sells 2,210 Shares Worth $92,999.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816388","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816388?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355554,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics CEO Abraham Ceesay sells 2,210 shares worth $92,999.37Rapport Therapeutics CEO Abraham Ceesay sold 2,210 common shares on July 27, 2026.Sales priced at USD 42.11 and USD 42.74.Dir","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL9rMfGk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics CEO Abraham Ceesay Sells 2,210 Shares Worth $92,999.37","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655169188","title":"Press Release: Bausch Health Announces Second Quarter 2026 Results, Raises Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2655169188","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655169188?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355500,"startTime":"0","endTime":"0","summary":"-- Second Quarter Consolidated Revenues of $2.85 billion, up 13% on a. Reported basis and 11% on an Organic 1 basis over the prior. -- GAAP Net Income Attributable to Bausch Health of $258 million and GAAP. -- GAAP Earnings per Diluted Share Attributable to Bausch Health of $0.68. compared to $0.40 in the prior year period; Adjusted Earnings per Diluted. Share 1 of $1.26 compared to $0.90 in the prior year period, an. -- Consolidated Adjusted EBITDA Attributable to Bausch Health 1 of. -- Raising full-year 2026 Revenue, Adjusted EBITDA 1, and Adjusted. on non-GAAP measures and non-GAAP ratios, please refer to the \"Non-GAAP. the end of this news release for a reconciliation of this and other. non-GAAP measures and ratios to the most directly comparable GAAP. measure.Second Quarter 2026 Revenue PerformanceTotal consolidated reported revenues were $2.85 billion for the second quarter of 2026, compared with $2.53 billion in the second quarter of 2025, an increase of $322 million, or 13","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHC","BK4022","BK4232","BK4007","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655815445","title":"60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655815445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655815445?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:03","pubTimestamp":1785355380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA1BG9RH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTPW","SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655811465","title":"60 Degrees Pharmaceuticals - Company to Request FDA Meeting on Nda Pathway for Tafenoquine in Babesiosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2655811465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655811465?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:03","pubTimestamp":1785355380,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA1BG9RH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655815597","title":"NYSE Order Imbalance 606104.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2655815597","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655815597?lang=en_us&edition=fundamental","pubTime":"2026-07-30 03:50","pubTimestamp":1785354604,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nAQN2MC6BU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0158827781.USD","LU0471298694.HKD","LU2028103732.USD","IE00B19Z9505.USD","LU0158827948.USD","LU2023251221.USD","ZTS","LU1236620834.HKD","LU0471298777.SGD","LU1059921491.USD","BK4585","BK4534","LU0345774631.USD","PAWZ","LU1236620750.USD","LU2111349929.HKD","LU0385154629.USD","LU1721429402.USD","LU1941712348.USD","BK4007","LU0107464264.USD","LU2360106947.USD","LU0345774391.USD","LU0079474960.USD","LU2308191902.HKD","LU1941712264.USD","BK4588","LU2089284900.SGD","LU0058720904.USD","LU1721429741.USD","LU2271345857.HKD","LU2089283258.USD","LU0289739699.SGD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655180198","title":"Merck Keeps Quarterly Dividend at $0.85 per Share; Payable Oct. 7 to Holders of Record on Sept. 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2655180198","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655180198?lang=en_us&edition=fundamental","pubTime":"2026-07-30 02:38","pubTimestamp":1785350312,"startTime":"0","endTime":"0","summary":"Price: 131.06, Change: -0.76, Percent Change: -0.58","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1037948541.HKD","LU1917777945.USD","LU0980610538.SGD","LU2433249047.HKD","LU0238689110.USD","LU1093756168.USD","LU0122379950.USD","LU2125909247.SGD","LU2361045086.USD","LU2125154778.USD","LU2361044865.SGD","LU2357627491.SGD","BK4007","LU2361044949.HKD","LU1066051811.HKD","IE0009355771.USD","IE00B2B36J28.USD","LU1934455194.USD","BK4533","IE00BSNM7G36.USD","RXL","BK4534","SG9999015341.SGD","LU0098860793.USD","LU1989771016.USD","LU1069347547.HKD","LU2461242641.AUD","IE00BLSP4239.USD","GDOC","LU1023059063.AUD","SG9999001176.USD","LU1035773651.USD","LU1571399168.USD","LU0234572021.USD","SG9999002224.SGD","LU1116320901.HKD","LU0320765489.SGD","LU0965508806.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1699723380.USD","LU1585245621.USD","LU0208291251.USD","IE00BN8TJ469.HKD","LU1066051225.USD","LU1116320737.USD","LU0265550946.USD","LU0130102774.USD","LU0432979614.USD","FTXH","LU0477156953.USD","SG9999001440.SGD","LU2023250504.SGD","IYH","LU0648001328.SGD","LU0942090050.USD","LU1934455277.USD","LU1430594728.SGD","SG9999014542.SGD","LU2106854487.HKD","LU2112291526.USD","LU0320765646.SGD","LU1061106388.HKD","SG9999014567.USD","FHLC","LU1934455863.HKD","SGXZ57979304.SGD","LU1057294990.SGD","LU1923622614.USD","IXJ","HRTS","IHE","LU0006306889.USD","IE00BLSP4452.SGD","LU2468319806.SGD","LU2023250843.SGD","LU0106261372.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0965509101.SGD","IE00B4R5TH58.HKD","LU1941712264.USD","LU1066051498.USD","BK4559","LU1974910355.USD","BMED","LU2125909593.SGD","LU1162221912.USD","LU0124676726.USD","BK4588","LU0265550359.USD","IE000M9KFDE8.USD","LU0861579265.USD","LU2491049909.HKD","LU1037948897.HKD","LU2089984988.USD","LU0985320562.USD","LU0130517989.USD","LU0689626769.HKD","LU1291159041.SGD","LU1093756325.SGD","MRK","LU0965509283.SGD","LU0868494708.USD","LU0070302665.USD","LU2491050154.USD","LU0965509010.AUD","SG9999014559.SGD","IE00B1BXHZ80.USD","LU2491050071.SGD","LU0868494617.USD","LU0266013472.USD","LU1989772840.SGD","JDOC","IE00BBT3K403.USD","LU1983299246.USD","SG9999002232.USD","SG9999015358.SGD","PPH","LU1989772923.USD","SG9999001176.SGD","BK4550","LU2360032135.SGD","LU1941712348.USD","LU0058720904.USD","PAWZ","TRUH","SG9999013999.USD","LU1929549753.HKD","LU2125154935.USD","BK4585","SG9999014575.USD","LU0289739699.SGD","BK4516","LU0211331839.USD","LU1201861249.SGD","IE0002141913.USD","LU0859254822.USD","VHT","LU1066053197.SGD","XLV","LU0203347892.USD","LU0203345920.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655189010","title":"Teva's Innovative Drug Portfolio Fuels Growth as Company Raises Outlook, Transitions to Direct NYSE Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2655189010","media":"Benzinga Earnings","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655189010?lang=en_us&edition=fundamental","pubTime":"2026-07-30 01:57","pubTimestamp":1785347820,"startTime":"0","endTime":"0","summary":"Teva revenue tops estimates despite an earnings miss. The company raises 2026 sales guidance and highlights strong brand growth.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/07/60772936/tevas-innovative-drug-portfolio-fuels-growth-as-company-raises-outlook-transitions-to-direct-nyse-listing","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA","BK4566","BK4588","LU1983299246.USD","LU2324357040.USD","BK4007","BK4585","BK4557","BK4559","BK4584","BK4596","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655289783","title":"Aurora UK Alpha Corrects Share Buyback Price and Updates Voting Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2655289783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655289783?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:37","pubTimestamp":1785343062,"startTime":"0","endTime":"0","summary":"Aurora Investment Trust PLC ( ($GB:ARR) ) has provided an announcement. Aurora UK Alpha PLC has corrected an earlier disclosure on a share buyback ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-corrects-share-buyback-price-and-updates-voting-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-corrects-share-buyback-price-and-updates-voting-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACB","BRKC","MSOS","BRKU","BK4007","BK4557","BRKW","BRKD","ACTV","ACKY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655897889","title":"Sanofi’s MenQuadfi Safety Study in Korea: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2655897889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655897889?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:31","pubTimestamp":1785342698,"startTime":"0","endTime":"0","summary":"Sanofi SA ($SNY) announced an update on their ongoing clinical study. Sanofi is running a post-marketing study in Korea to track how its MenQuadfi ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sanofis-menquadfi-safety-study-in-korea-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sanofis-menquadfi-safety-study-in-korea-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4007","ISBC","SNYNF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655897860","title":"Sanofi Targets Dual RSV–HMPV Opportunity With Fresh Phase 1/2 Vaccine Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2655897860","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655897860?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:31","pubTimestamp":1785342673,"startTime":"0","endTime":"0","summary":"Sanofi SA ($SNY) announced an update on their ongoing clinical study. Sanofi SA (SNY) has launched a Phase 1/2 study in adults 60+ to test a new co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sanofi-targets-dual-rsv-hmpv-opportunity-with-fresh-phase-1-2-vaccine-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sanofi-targets-dual-rsv-hmpv-opportunity-with-fresh-phase-1-2-vaccine-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFXG1179.USD","PRTO","BK4588","SNYNF","BK4585","SNY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655897888","title":"Takeda’s Pediatric GERD Trial Update: What Dexlansoprazole Data Could Mean for TAK Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2655897888","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655897888?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:31","pubTimestamp":1785342667,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) has updated a Phase 2 study testing its GERD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-pediatric-gerd-trial-update-what-dexlansoprazole-data-could-mean-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-pediatric-gerd-trial-update-what-dexlansoprazole-data-could-mean-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","ISBC","BK4007","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":0.0163},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0675},{"period":"1year","weight":0.1632},{"period":"ytd","weight":0.0864}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction